Skip to main content
. 2014 Feb 26;9(2):e89741. doi: 10.1371/journal.pone.0089741

Figure 2. Rates of neurological-disease-free-survival according to the time of IRBD diagnosis in the first 44 patients from the cohort (doted line) and the remaining 130 (continuous line).

Figure 2

HHS Vulnerability Disclosure